These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 19046239

  • 1. The metabolic syndrome is related to albuminuria in Type 2 diabetes.
    Bianchi C, Penno G, Daniele G, Russo E, Giovannitti MG, Del Prato S, Miccoli R.
    Diabet Med; 2008 Dec; 25(12):1412-8. PubMed ID: 19046239
    [Abstract] [Full Text] [Related]

  • 2. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO, Ma RC, So WY, Yang XL, Kong AP, Ozaki R, Ko GT, Chow CC, Cockram CS, Chan JC, Tong PC.
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [Abstract] [Full Text] [Related]

  • 3. Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes.
    Esteghamati A, Rashidi A, Khalilzadeh O, Ashraf H, Abbasi M.
    Acta Diabetol; 2010 Jun; 47(2):125-30. PubMed ID: 19479185
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
    Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, Wang W, Zuo Y, Gu H, Xiang K.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Japan Diabetes Clinical Data Management Study Group.
    Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626
    [Abstract] [Full Text] [Related]

  • 6. Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes.
    Bouchi R, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Hanai K, Tanaka N, Ishii A, Iwamoto Y.
    Diabet Med; 2010 May; 27(5):538-43. PubMed ID: 20536949
    [Abstract] [Full Text] [Related]

  • 7. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
    Ito H, Takeuchi Y, Ishida H, Antoku S, Abe M, Mifune M, Togane M.
    Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
    [Abstract] [Full Text] [Related]

  • 8. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
    Murussi M, Campagnolo N, Beck MO, Gross JL, Silveiro SP.
    Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
    [Abstract] [Full Text] [Related]

  • 9. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16.
    Yokoyama H, Oishi M, Kawai K, Sone H, Japan Diabetes Clinical Data Management Study Group.
    Diabet Med; 2008 Dec; 25(12):1426-32. PubMed ID: 19046241
    [Abstract] [Full Text] [Related]

  • 10. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
    Costacou T, Ellis D, Fried L, Orchard TJ.
    Am J Kidney Dis; 2007 Nov; 50(5):721-32. PubMed ID: 17954285
    [Abstract] [Full Text] [Related]

  • 11. Treatment of metabolic syndrome slows progression of diabetic nephropathy.
    Duran-Perez EG, Almeda-Valdes P, Cuevas-Ramos D, Campos-Barrera E, Muñoz-Hernandez L, Gomez-Perez FJ.
    Metab Syndr Relat Disord; 2011 Dec; 9(6):483-9. PubMed ID: 21875335
    [Abstract] [Full Text] [Related]

  • 12. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus.
    Kim ES, Kwon HS, Ahn CW, Lim DJ, Shin JA, Lee SH, Cho JH, Yoon KH, Kang MI, Cha BY, Son HY.
    J Diabetes Complications; 2011 Dec; 25(5):309-13. PubMed ID: 21130003
    [Abstract] [Full Text] [Related]

  • 13. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [Abstract] [Full Text] [Related]

  • 14. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH, CARDS Investigators.
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [Abstract] [Full Text] [Related]

  • 15. Metabolic syndrome and chronic kidney disease.
    Ruan X, Guan Y.
    J Diabetes; 2009 Dec; 1(4):236-45. PubMed ID: 20923524
    [Abstract] [Full Text] [Related]

  • 16. Is a reduced estimated glomerular filtration rate a risk factor for stroke in patients with type 2 diabetes?
    Bouchi R, Babazono T, Nyumura I, Toya K, Hayashi T, Ohta M, Hanai K, Kiuchi Y, Suzuki K, Iwamoto Y.
    Hypertens Res; 2009 May; 32(5):381-6. PubMed ID: 19325564
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.
    Stengel B, Jaussent I, Guiserix J, Bourgeon B, Papoz L, Favier F, REDIA Study Group.
    Diabetes Metab; 2007 Dec; 33(6):444-52. PubMed ID: 18006351
    [Abstract] [Full Text] [Related]

  • 18. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P.
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [Abstract] [Full Text] [Related]

  • 19. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study.
    Nag S, Bilous R, Kelly W, Jones S, Roper N, Connolly V.
    Diabet Med; 2007 Jan; 24(1):10-7. PubMed ID: 17227319
    [Abstract] [Full Text] [Related]

  • 20. Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study.
    Hermans MM, Henry RM, Dekker JM, Nijpels G, Heine RJ, Stehouwer CD.
    J Hypertens; 2008 Apr; 26(4):791-7. PubMed ID: 18327090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.